National Research Corporation logo

National Research Corporation (NRC)

Market Closed
19 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
21. 98
-0.03
-0.1363%
$
480.26M Market Cap
33.66 P/E Ratio
0.64% Div Yield
104,090 Volume
0 Eps
$ 22.01
Previous Close
Add Transaction
Day Range
21.7 22.87
Year Range
11.01 23.68
Want to track NRC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NRC's Q2 Earnings Rise Y/Y on Cost Control and TRCV Growth

NRC's Q2 Earnings Rise Y/Y on Cost Control and TRCV Growth

National Research's Q2 adjusted earnings improved year over year on cost control and TRCV gains, but a one-time executive expense weighed on margins.

Zacks | 1 year ago
NRC Q1 Earnings Dip Y/Y Amid Rising Interest Costs, Shares Up 13%

NRC Q1 Earnings Dip Y/Y Amid Rising Interest Costs, Shares Up 13%

National Research reports a year-over-year decline in Q1 earnings, pressured by rising interest costs, declining revenues, and higher debt levels amid ongoing sales force expansion.

Zacks | 1 year ago
Amazon-Owned One Medical CEO Trent Green to Move to NRC Health

Amazon-Owned One Medical CEO Trent Green to Move to NRC Health

The CEO of Amazon-owned One Medical, Trent Green, will leave that position to become CEO of National Research Corporation, a publicly traded provider of healthcare solutions doing business as NRC Health. NRC Health announced the move in a Wednesday (March 5) press release, saying Green will join the company June 1.

Pymnts | 1 year ago
National Research's Q4 Earnings Drop Y/Y, Stock Falls 9%

National Research's Q4 Earnings Drop Y/Y, Stock Falls 9%

NRC's Q4 EPS drops to 28 cents despite revenue growth, hit by rising costs and higher interest expenses.

Zacks | 1 year ago
Zacks Initiates Coverage of NRC Health With Neutral Recommendation

Zacks Initiates Coverage of NRC Health With Neutral Recommendation

Discover why Zacks has given NRC Health a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Dive into the company's AI innovations, strategic partnerships, and financial resilience, along with the challenges of revenue declines, rising debt and stiff competition.

Zacks | 1 year ago